Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Molecular Biomarker Testing and Targeted Therapy Patterns in Patients with Acute Myelogenous Leukemia (AML) in Community Health Systems in the United States: A Real-World Data Analysis

Francesca Coutinho, Zartash Gul, Anna B. Berry, Michael A. Thompson, Christopher Allen Willner, II, Sowjanya Vuyyala, Haley McCracken, Katherine Geverd, Jeanna Wallenta Law, Frank M. Wolf, Thomas D. Brown, Philip Kuriakose

Blood (2021) 138 (Supplement 1): 4443.

https://doi.org/10.1182/blood-2021-148634

Published: 2021

Journal Articles

Analyzing How Elderly Acute Myeloid Leukemia Patients Are Treated, an Institutional Experience

Christopher Allen Willner, II, DO, Mohammad Muhsin Chisti, MD, Michaela Soriano, James Huang, MD

Blood (2019) 134 (Supplement_1): 5849.

https://doi.org/10.1182/blood-2019-121560

Published: 2019

Journal Articles

Demographics and Survival in Primary Effusion Lymphoma: SEER Database Analysis

John Khoury, MD, Christopher Allen Willner, DO, Bolanle Gbadamosi, MD, Susanna Gaikazian, MD, Ishmael Jaiyesimi, DO, MS

Blood (2018) 132 (Supplement 1): 5397.

https://doi.org/10.1182/blood-2018-99-115473

Published: 2018

Journal Articles

Activation of the LMO2 oncogene through a somatically acquired neomorphic promoter in T-cell acute lymphoblastic leukemia

Blood (2017) 129 (24): 3221–3226.

https://doi.org/10.1182/blood-2016-09-742148

Published: 2017

Includes: Supplemental data

Journal Articles

KIR gene haplotype: an independent predictor of clinical outcome in MDS patients

Blood (2016) 128 (24): 2819–2823.

https://doi.org/10.1182/blood-2016-05-713099

Published: 2016

Includes: Supplemental data

Journal Articles

Prevalence of TP53 Mutations in Del(17p) Myeloma: Spectrum of Mutations and Effect on Survival

Melody Chin, BSc, MSc, Jonathan Sive, MBBS, Christopher Allen, BSc, Claire Roddie, MD PhD, Selina J Chavda, MBBS BSc MRCP, Dean Smith, MBBS, Rakesh Popat, Ali Rismani, MBBS, Shirley D'Sa, Neil Rabin, Rosemary E. Gale, PhD BSc, Kwee L Yong

Blood (2016) 128 (22): 4455.

https://doi.org/10.1182/blood.V128.22.4455.4455

Published: 2016

Journal Articles

Activation of the LMO2 Oncogene in T-ALL through a Somatically Acquired Neomorphic Promoter

Sunniyat Rahman, PhD DIC, MBiochem, Michael Magnussen, MSc, BSc, Theresa E. León, PhD MSc, BSc, Nadine Farah, FRCPath, MBBChir, MA, MRCP, Brian J. Abraham, PhD BSc, Zhaodong Li, PhD, Krisztina Z. Alapi, PhD MSc, BSc, Rachel J. Mitchell, MSc, Bsc, Tom Naughton, MSc, BSc, Adele K. Fielding, MB BS, PhD FRCP, FRCPath, Arnold Pizzey, Sophia Bustraan, BSc, Christopher Allen, BSc, Rosemary E. Gale, PhD BSc, David C. Linch, MD MRCP, MB BCh, BA, Richard A. Young, PhD BS, A. Thomas Look, MD, Marc R Mansour, MBChB, MRCP, PhD FRCPath

Blood (2016) 128 (22): 733.

https://doi.org/10.1182/blood.V128.22.733.733

Published: 2016

Journal Articles

The Impact of Different DNMT3A Mutations on Outcome in Younger Adults with Acute Myeloid Leukemia

Rosemary E Gale, Katarina Lamb, BSc, Christopher Allen, BSc, Dima El-Sharkawi, MBBS, Cassandra Stowe, MSc, Sarah Jenkinson, MSc, Steven Tinsley, PhD, Glenda Dickson, PhD, Alan K. Burnett, MD, Robert K. Hills, MA, MSc, DPhil, David C Linch, FMedSci

Blood (2014) 124 (21): 67.

https://doi.org/10.1182/blood.V124.21.67.67

Published: 2014

Journal Articles

X chromosome inactivation analysis reveals a difference in the biology of ET patients with JAK2 and CALR mutations

Christopher Allen, Jonathan R. Lambert, David C. Linch, Rosemary E. Gale

Blood (2014) 124 (13): 2091–2093.

https://doi.org/10.1182/blood-2014-06-580183

Published: 2014

Journal Articles

The Cellular and Molecular Mechanisms of Neutropenia in Barth Syndrome

Andrew A Aprikyan, PhD, Vahagn Makaryan, MD, Willem Kulik, PhD, Frederic Vaz, PhD, Christopher Allen, Yigal Dror, MD, David C. Dale, MD

Blood (2011) 118 (21): 1105.

https://doi.org/10.1182/blood.V118.21.1105.1105

Published: 2011

Journal Articles

Synthetic lethality: exploiting the addiction of cancer to DNA repair

Montaser Shaheen, Christopher Allen, Jac A. Nickoloff, Robert Hromas

Blood (2011) 117 (23): 6074–6082.

https://doi.org/10.1182/blood-2011-01-313734

Published: 2011

Journal Articles

A Distinct Signature of Natural Killer Cell KIR Gene Frequencies In Secondary AML Compared with De Novo AML and Normal Controls

Kate Stringaris, MD, MRCP, FRCPath, A. John Barrett, MD, Robert Hills, MA, MSc, DPhil, David C Linch, MD, FMedSci, Rosemary Gale, PhD, Christopher Allen, Paula Garland, MBBS, MRCP, Ruhena Sargent, Hugues de Lavallade, Abdullah Alsuliman, Ahmad Khoder, Dr, Ian H Gabriel, Dr, Takuya Sekine, Alan Burnett, Katayoun Rezvani, Jane F. Apperley

Blood (2010) 116 (21): 1697.

https://doi.org/10.1182/blood.V116.21.1697.1697

Published: 2010

Journal Articles

The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia

Rosemary E. Gale, Claire Green, Christopher Allen, Adam J. Mead, Alan K. Burnett, Robert K. Hills, David C. Linch

Blood (2008) 111 (5): 2776–2784.

https://doi.org/10.1182/blood-2007-08-109090

Published: 2008

Includes: Supplemental data

Journal Articles

Mutation of the Wilms’ Tumor 1 Gene Is a Poor Prognostic Factor Associated with Chemoresistance in Normal Karyotype Acute Myeloid Leukemia.

Priya Virappane, Rosemary E. Gale, Robert Hills, Ioannis Kakkas, Karin Summers, Jane Stevens, Claire Green, Christopher Allen, Alan K. Burnett, David C. Linch, Dominique Bonnet, T. Andrew Lister, Jude Fitzgibbon

Blood (2007) 110 (11): 361.

https://doi.org/10.1182/blood.V110.11.361.361

Published: 2007

Journal Articles

A Genome-Wide Map of Acquired Uniparental Disomy in Acute Myeloid Leukemia.

Manu Gupta, Manoj Raghavan, Rosemary E. Gale, Claude Chelala, Christopher Allen, Gael Molloy, Tracy Chaplin, David C. Linch, Jean-Baptiste Cazier, Bryan Young

Blood (2007) 110 (11): 996.

https://doi.org/10.1182/blood.V110.11.996.996

Published: 2007

NARROW

Molecular Biomarker Testing and Targeted Therapy Patterns in Patients with Acute Myelogenous Leukemia (AML) in Community Health Systems in the United States: A Real-World Data Analysis

Analyzing How Elderly Acute Myeloid Leukemia Patients Are Treated, an Institutional Experience

Demographics and Survival in Primary Effusion Lymphoma: SEER Database Analysis

Activation of the LMO2 oncogene through a somatically acquired neomorphic promoter in T-cell acute lymphoblastic leukemia

KIR gene haplotype: an independent predictor of clinical outcome in MDS patients

Prevalence of TP53 Mutations in Del(17p) Myeloma: Spectrum of Mutations and Effect on Survival

Activation of the LMO2 Oncogene in T-ALL through a Somatically Acquired Neomorphic Promoter

The Impact of Different DNMT3A Mutations on Outcome in Younger Adults with Acute Myeloid Leukemia

X chromosome inactivation analysis reveals a difference in the biology of ET patients with JAK2 and CALR mutations

The Cellular and Molecular Mechanisms of Neutropenia in Barth Syndrome

Synthetic lethality: exploiting the addiction of cancer to DNA repair

A Distinct Signature of Natural Killer Cell KIR Gene Frequencies In Secondary AML Compared with De Novo AML and Normal Controls

The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia

Mutation of the Wilms’ Tumor 1 Gene Is a Poor Prognostic Factor Associated with Chemoresistance in Normal Karyotype Acute Myeloid Leukemia.

A Genome-Wide Map of Acquired Uniparental Disomy in Acute Myeloid Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only